Dr Kate Cameron, CEO of Cytochroma, has made her debut appearance in Times Square. The spotlight follows on from Cytochroma being accepted to Morgan Stanley‘s 2025 Inclusive & Sustainable Ventures Cohort.
Cytochroma is just one of 33 innovative startups and nonprofits to be included in the programme, with cohort members being involved in industries ranging from healthcare, transportation, and accounting to sustainability challenges such as waste reduction and extreme weather.
Congratulations to Dr Kate Cameron and Cytochroma, it is fantastic to see your innovative approach to accelerating drug development recognised on a global stage.
Dr Kate Cameron, CEO of Cytochroma, debuts in Times Square
